Virginia L Cunningham

Summary

Publications

  1. doi request reprint Human health risk assessment of carbamazepine in surface waters of North America and Europe
    Virginia L Cunningham
    Sustainability Sciences LLC, 126 Moonflower Road, Hatboro, PA 19040, USA
    Regul Toxicol Pharmacol 56:343-51. 2010
  2. doi request reprint Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment
    Virginia L Cunningham
    GlaxoSmithKline, 1 Franklin Plaza, 200 N 16th Street, Philadelphia, PA 19102, USA
    Regul Toxicol Pharmacol 53:39-45. 2009
  3. doi request reprint Predicting concentrations of trace organic compounds in municipal wastewater treatment plant sludge and biosolids using the PhATE™ model
    Virginia L Cunningham
    Sustainability Sciences LLC, Hatboro, Pennsylvania 19040, USA
    Integr Environ Assess Manag 8:530-42. 2012
  4. doi request reprint Exposure assessment of 17alpha-ethinylestradiol in surface waters of the United States and Europe
    Robert Hannah
    GlaxoSmithKline, Philadelphia, PA 19102, USA
    Environ Toxicol Chem 28:2725-32. 2009
  5. ncbi request reprint Environmental risk assessment of paroxetine
    Virginia L Cunningham
    Corporate Environment, Health and Safety, GlaxoSmithKline, 2200 Renaissance Boulevard, Suite 105, King of Prussia, Pennsylvania 19406, USA
    Environ Sci Technol 38:3351-9. 2004

Detail Information

Publications5

  1. doi request reprint Human health risk assessment of carbamazepine in surface waters of North America and Europe
    Virginia L Cunningham
    Sustainability Sciences LLC, 126 Moonflower Road, Hatboro, PA 19040, USA
    Regul Toxicol Pharmacol 56:343-51. 2010
    ..This assessment indicates that CBZ and its major metabolites have high MOS (>>1) and thus should have no appreciable risk to human health through environmental exposures based on available human data...
  2. doi request reprint Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment
    Virginia L Cunningham
    GlaxoSmithKline, 1 Franklin Plaza, 200 N 16th Street, Philadelphia, PA 19102, USA
    Regul Toxicol Pharmacol 53:39-45. 2009
    ....
  3. doi request reprint Predicting concentrations of trace organic compounds in municipal wastewater treatment plant sludge and biosolids using the PhATE™ model
    Virginia L Cunningham
    Sustainability Sciences LLC, Hatboro, Pennsylvania 19040, USA
    Integr Environ Assess Manag 8:530-42. 2012
    ..Finally, comparison of PECs to measured concentrations can also be used to identify the need for fate studies of compounds of interest in biosolids...
  4. doi request reprint Exposure assessment of 17alpha-ethinylestradiol in surface waters of the United States and Europe
    Robert Hannah
    GlaxoSmithKline, Philadelphia, PA 19102, USA
    Environ Toxicol Chem 28:2725-32. 2009
    ....
  5. ncbi request reprint Environmental risk assessment of paroxetine
    Virginia L Cunningham
    Corporate Environment, Health and Safety, GlaxoSmithKline, 2200 Renaissance Boulevard, Suite 105, King of Prussia, Pennsylvania 19406, USA
    Environ Sci Technol 38:3351-9. 2004
    ..Any compounds in the environment as a result of the biodegradation of PM should be innocuous polar byproducts that should not exert any toxic effects...